Dr. Daniel Cameron

Dr. Daniel Cameron Dr. Daniel Cameron is a nationally recognized leader in the diagnosis and treatment of Lyme disease and other tick-borne infections. danielcameronmd.com
(206)

Dr. Daniel Cameron, MD, MPH is a board certified internist and epidemiologist with a private practice in Westchester County, New York - Dr. Daniel Cameron & Associates. He is a nationally recognized leader for his expertise in the diagnosis and treatment of Lyme disease and other tick borne infections. Dr. Cameron has been treating patients with tick borne diseases for more than 30 years and treat

s both children and adults. He is one of the founders of the International Lyme and Associated Diseases Society (ILADS) and the organization's past President. Dr. Cameron has published numerous scientific papers and is the lead author on ILADS' evidence-based treatment guidelines. He has presented at international medical conferences and seminars on tick borne diseases and is a passionate advocate for patients.

Why is a diagnosis of Lyme disease so often delayed?Were you diagnosed promptly?
06/05/2026

Why is a diagnosis of Lyme disease so often delayed?

Were you diagnosed promptly?

Delayed diagnosis, travel burdens, insurance barriers, and stigma make Lyme disease care difficult for many patients.

Are you afraid of a Herxheimer reaction? If so, listen to this.
06/02/2026

Are you afraid of a Herxheimer reaction? If so, listen to this.

Were you ever afraid of starting treatment for Lyme disease over fe...

Occupational Lyme Disease: Which Workers Face the Highest Risk?Occupational Lyme disease refers to Lyme disease acquired...
06/01/2026

Occupational Lyme Disease: Which Workers Face the Highest Risk?

Occupational Lyme disease refers to Lyme disease acquired through workplace exposure.

Are you or a family member at higher risk because of your occupation?

Occupational Lyme disease risk is highest for outdoor workers exposed to ticks through forestry, farming, and field work

While service members train for visible threats, tiny ticks are carrying emerging health risks closer to home. The MilTI...
05/30/2026

While service members train for visible threats, tiny ticks are carrying emerging health risks closer to home.

The MilTICK SURE Path program recently detected ticks positive for Powassan virus in Connecticut, Massachusetts, and for the first time, Maryland.

The program also identified the first Heartland virus–positive tick at Fort Knox, Kentucky.

READ PATIENT CASE: A 24-year-old Army officer's military career ends after he developed complications from Lyme disease.
https://danielcameronmd.com/lyme-podcast-lyme-disease-forces-officer-out-military/

While service members train for visible threats, a nearly invisible one is emerging from our own backyards. Rare but dangerous viruses carried by ticks no bigger than a sesame seed are being detected on and around U.S. military installations, and a proactive public health program is giving us the ea...

New York State has reported its first confirmed case of Bourbon virus.A Long Island man initially tested negative for Ly...
05/29/2026

New York State has reported its first confirmed case of Bourbon virus.

A Long Island man initially tested negative for Lyme disease, but as his condition continued to worsen, doctors at Stony Brook conducted additional antibody testing. After several months, he tested positive for the Bourbon virus infection.

There's no vaccine for the Bourbon virus, nor medicine to treat it, according to the U.S. Centers for Disease Control and Prevention.

As summer approaches, are you considering travelling and wondering if it's possible or will it worsen your Lyme symptoms...
05/28/2026

As summer approaches, are you considering travelling and wondering if it's possible or will it worsen your Lyme symptoms? I discuss the topic in this brief video.

As a Lyme disease expert, I often hear the same concern: “Is travel...

Why do some people still struggle with Lyme disease symptoms even after treatment? It could be due to “persister” cells ...
05/27/2026

Why do some people still struggle with Lyme disease symptoms even after treatment?

It could be due to “persister” cells — forms of the Lyme bacteria (Borrelia burgdorferi) that may be able to tolerate antibiotics, as demonstrated in laboratory studies.

Lyme persister cells may explain treatment failure. Learn how these forms behave and why symptoms may persist.

According to patients participating in MyLymeData, 60% report having at least one co-infection.
05/26/2026

According to patients participating in MyLymeData, 60% report having at least one co-infection.

Approximately 60% of MyLymeData patients report co-infections. This is life saving information as many physicians do not consider coinfections or may test only for select coinfections.

How many others have confections? Add your Lyme data to MyLymeData. https://mylymedata.org

Learn more about co-infections in this FREE issue of the LymeTimes: https://www.lymedisease.org/coinfections-lyme-times/

International Lyme disease studies continue to show the same concerning patterns: delayed diagnosis, neurologic and psyc...
05/23/2026

International Lyme disease studies continue to show the same concerning patterns: delayed diagnosis, neurologic and psychiatric complications and persistent symptoms.

Despite differences in surveillance and testing between countries, reports from Canada, Germany, and Mexico describe many of the same challenges in recognizing and treating Lyme disease.

International Lyme disease studies report delayed diagnosis, neurologic symptoms, psychiatric complications, and recognition gaps.

According to a new study, Tafenoquine may become a promising new treatment option for babesiosis, particularly in severe...
05/22/2026

According to a new study, Tafenoquine may become a promising new treatment option for babesiosis, particularly in severe or relapsing cases. The drug is already FDA-approved for malaria prevention but it is not yet FDA-approved specifically for babesiosis.

According to the authors, "the first human case of B. microti treated with tafenoquine was reported in an immunocompromised patient with a history of rituximab treatment who was resistant to both atovaquone and azithromycin. Treatment with tafenoquine with a course of 200 mg for 3 consecutive days followed by 200 mg once per week resulted in negative blood smears and PCR within 6 weeks."

Tafenoquine can be a useful adjunct for the treatment of highly immunocompromised patients experiencing relapsing babesiosis caused by B. microti.

Address

344 Main Street, Suite 104
Mount Kisco, NY
10549

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Dr. Daniel Cameron posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category